跳至主要内容
临床试验/CTRI/2013/03/003488
CTRI/2013/03/003488已完成Phase 3 4

To study the safety and efficacy of use of Mifepristone along with Misoprostol for medical termination of pregnancy in second trimester (12-20weeks)

Dr Pushpa Junghare1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年2月28日最近更新:

试验速览

阶段
Phase 3 4
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Safety and efficacy of use of Mifepristone along with Misoprostol for second trimester medical termination of pregnancy(12-20weeks)

研究概览

简要总结

Combination of Mifepristone and Misoprostol has been successfully used for medical termination of pregnancy upto 12 weeks.In this study we are using single dose Mifepristone and Misoprostol for second trimester termination of pregnancy (12-20 ) weeks. Till date we have enrolled 48 cases in our study. Induction to abortion interval was approximately 12-16 hours. No major complications were seen.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Women wanting to undergo second trimester medical termination of pregnancy (12-20weeks).

排除标准

  • Known hypersensitivity to Mifepristone or Misoprostol Women with medical renal disease,liver disease Women with heart disease Hb less than 8gm%.

结局指标

主要结局

Safety and efficacy of use of Mifepristone along with Misoprostol for second trimester medical termination of pregnancy(12-20weeks)

时间窗: 12-20weeks

次要结局

  • 1)addional intervention required(2)estimation of blood loss)

研究者

发起方
Dr Pushpa Junghare
申办方类型
Other [Professor and HOD(OBGY)]

研究点 (1)

Loading locations...

相似试验